NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Immunology



Data on immunology detailed by researchers at University of Heidelberg, Institute of Immunology



May 27th, 2008

New research, 'Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties,' is the subject of a report. According to recent research from Heidelberg, Germany, "The most important antigen-presenting cells are dendritic cells (DCs), which play a central role in the initiation of immunity and tolerance. Their immunoregulatory properties offer the potential of donor-specific control of graft rejection after organ transplantation."

"It has not been clarified which DC subpopulations mediate tolerance, and the use of natural DCs for therapeutic applications is therefore problematic. Suppressive DCs can be...


Source: Cancer Weekly (2008-05-27)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login